3 Details to Review Before Vaginal Prasterone

If pain has made intimacy something you have to prepare for or avoid, a treatment discussion may feel overdue. When vaginal prasterone comes up, ask the clinician to connect the recommendation to your symptoms and history. You can ask about comfort without minimizing how much it matters.

Three prescribing details

1. The symptom being treated. Ask what the examination established and why this option is being considered. Its approved indication is specific to menopausal painful sex, not every cause of discomfort during intimacy.¹

2. Any unexplained bleeding. Undiagnosed abnormal genital bleeding is a contraindication. Persistent or recurring postmenopausal bleeding needs evaluation before treatment is considered.¹ Tell the clinician about bleeding before beginning.

3. Your breast history. The label includes a warning about current or past breast cancer and states that Intrarosa has not been studied in women with that history.¹ Ask the treating team to assess suitability; vaginal use does not settle that question.

Ask what to expect and report

Vaginal discharge is a commonly reported adverse effect.¹ Ask how to use the supplied applicator, which changes to report and when the response will be reviewed. Keep the full patient information with the treatment instructions.

You can write down the question that feels most uncomfortable and hand it to the clinician. Ask them to explain the choices and how to contact the team if you need clarification afterward.

My Body Changed. Now What? includes a symptom diary, Change Map and Visit Brief. Use them to organize your concerns and questions. See the book.